Nolan Katrina M, Jordan Andrea P O, Hoxie James A
University of Pennsylvania, 356 Biomedical Research Building II/III, 421 Curie Blvd., Philadelphia, PA 19104, USA.
J Virol. 2008 Jan;82(2):664-73. doi: 10.1128/JVI.01793-07. Epub 2007 Oct 31.
The human immunodeficiency virus type 1 (HIV-1) V3 loop is critical for coreceptor binding and principally determines tropism for the CCR5 and CXCR4 coreceptors. The recent crystallographic resolution of V3 shows that its base is closely associated with the conserved coreceptor binding site on the gp120 core, whereas more distal regions protrude toward the cell surface, likely mediating interactions with coreceptor extracellular loops. However, these V3-coreceptor interactions and the structural basis for CCR5 or CXCR4 specificity are poorly understood. Using the dual-tropic virus HIV-1(R3A), which uses both CCR5 and CXCR4, we sought to identify subdomains within V3 that selectively mediate R5 or X4 tropism. An extensive panel of V3 mutants was evaluated for effects on tropism and sensitivity to coreceptor antagonists. Mutations on either side of the V3 base (residues 3 to 8 and 26 to 33) ablated R5 tropism and made the resulting X4-tropic Envs more sensitive to the CXCR4 inhibitor AMD3100. When mutations were introduced within the V3 stem, only a deletion of residues 9 to 12 on the N-terminal side ablated X4 tropism. Remarkably, this R5-tropic Delta9-12 mutant was completely resistant to several small-molecule inhibitors of CCR5. Envs with mutations in the V3 crown (residues 13 to 20) remained dual tropic. Similar observations were made for a second dual-tropic isolate, HIV-1(89.6). These findings suggest that V3 subdomains can be identified that differentially affect R5 and X4 tropism and modulate sensitivity to CCR5 and CXCR4 inhibitors. These studies provide a novel approach for probing V3-coreceptor interactions and mechanisms by which these interactions can be inhibited.
1型人类免疫缺陷病毒(HIV-1)的V3环对于共受体结合至关重要,并且主要决定了对CCR5和CXCR4共受体的嗜性。最近V3的晶体学解析表明,其基部与gp120核心上保守的共受体结合位点紧密相关,而更远端的区域向细胞表面突出,可能介导与共受体细胞外环的相互作用。然而,这些V3-共受体相互作用以及CCR5或CXCR4特异性的结构基础仍知之甚少。利用双嗜性病毒HIV-1(R3A),其同时利用CCR5和CXCR4,我们试图鉴定V3内选择性介导R5或X4嗜性的亚结构域。评估了大量V3突变体对嗜性和对共受体拮抗剂敏感性的影响。V3基部两侧(第3至8位和第26至33位残基)的突变消除了R5嗜性,并使产生的X4嗜性包膜蛋白对CXCR4抑制剂AMD3100更敏感。当在V3茎内引入突变时,只有N端第9至12位残基的缺失消除了X4嗜性。值得注意的是,这种R5嗜性的Δ9-12突变体对几种CCR5小分子抑制剂完全耐药。V3冠部(第13至20位残基)有突变的包膜蛋白仍为双嗜性。对第二个双嗜性分离株HIV-1(89.6)也有类似的观察结果。这些发现表明,可以鉴定出对R5和X4嗜性有不同影响并调节对CCR5和CXCR4抑制剂敏感性的V3亚结构域。这些研究为探究V3-共受体相互作用以及抑制这些相互作用的机制提供了一种新方法。